Ellen F. Eaton

Ellen F. Eaton

Auto-generated profile, based on publicly available information

Ellen F. Eaton

Division of Infectious Diseases, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
EEEllen F Eaton
Ellen F Eaton
AWAndrew O Westfall
Andrew O Westfall
BMBrandi McClesky
Brandi McClesky
CPCayce S Paddock
Cayce S Paddock
PLPeter S Lane
Peter S Lane
RLRachael A Lee
Rachael A Lee
Hospitalized persons who inject drugs are at a greater risk of adverse hospital outcomes including discharge against medical advice, inpatient illicit drug use, overdose, and death. However, there are limited data on the frequency and outcomes of these events in the United States. This retrospective analysis included patients with injection-related infections receiving a protocol for injection drug use (IDU) at University of Alabama at Birmingham Hospital from 2016 to 2017. In-hospital IDU was suspected or reported drug usage plus confirmatory drug screen, and documented discharges “against medical advice” were deemed patient-directed discharges (PDD). We analyzed the frequency of and associations between in-hospital IDU, PDD, 30-day readmission, and deaths (between 2016 and 2019) using McNemar’s tests. Logistic regression models evaluated the association between PDD, in-hospital IDU, readmission, and death. Overall, 83 patients met inclusion criteria: 28 (34%) with in-hospital IDU, 12 (14%) PDD, 9 (11%) died, and 12 (14%) 30-day readmission. In-hospital IDU was significantly associated with PDD (P = .003), 30-day readmission (P = .005), and death (P = .0003). Patient-directed discharges and 30-day readmission were not significantly associated with death nor with each other. In a cohort of patients receiving inpatient care for injection-related infections, illicit drug use, PDD, 30-day readmissions, and death were common. Furthermore, patients who use illicit drugs while hospitalized are significantly more likely to leave early, be readmitted, and/or die. We must design models of care that prevent adverse outcomes, including drug use and PDD, to reduce barriers to evidence-based treatment of infections.

25 August 2018 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
EEEllen F Eaton
Ellen F Eaton
RMRonnie E Mathews
Ronnie E Mathews
PLPeter S Lane
Peter S Lane
CPCayce S Paddock
Cayce S Paddock
JRJorge Martin Rodriguez
Jorge Martin Rodriguez
RLRachael A Lee
Rachael A Lee
A 9-point risk assessment identified persons with a history of injection drug use who were safe for discharge. “Low-risk” patients were discharged with outpatient antibiotics; others continued inpatient treatment. Use of the assessment reduced the mean length of stay by 20 days and total direct cost by 33%, creating capacity for an additional 333 patients.

16 January 2018 in AIDS Research and Therapy
Verified
Journal Article
Open access
PDF file
LSLauren A. Saag
Lauren A. Saag
ATAshutosh R. Tamhane
Ashutosh R. Tamhane
DBD. Scott Batey
D. Scott Batey
MMMichael J. Mugavero
Michael J. Mugavero
EEEllen F. Eaton
Ellen F. Eaton
Mental health (MH) comorbidities reduce retention in care for persons living with HIV (PLWH) and are associated with poor health outcomes. Optimizing retention in primary care is vital, as poor retention is associated with delayed receipt of antiretroviral (ARV) therapy, ARV non-adherence, and poor health outcomes, including failure to suppress viral load, decreased CD4 counts, and clinically significant ARV drug resistance. We hypothesized that MH service utilization would be associated with improved retention in care for patients with HIV and MH comorbidities. This is a retrospective analysis of PLWH initiating outpatient HIV health care at a university-affiliated HIV clinic between January 2007 and December 2013. We examined the association between MH service utilization and retention in care, the outcome of interest, using univariate and multivariable logistic regression. Overall, 627 (84.4%) out of 743 patients were retained in care using the Health Resources & Services Administration HIV/AIDS Bureau (HRSA/HAB) metric. A multivariable model adjusted for several sociodemographic factors, MH comorbidities, and MH service utilization. The results suggest that lack of health insurance (public ORadj = 0.3, p < 0.01; no insurance ORadj = 0.4, p < 0.01) and ≥ 3 MH comorbidities (ORadj = 0.3, P = 0.01) were associated with decreased retention in care. Conversely, older age (> 45 years, ORadj. = 1.6, p = 0.14) and ≥ 3 MH service utilization visits (ORadj. = 6.8, p < 0.01) were associated with increased retention in care. Even in the absence of documented MH comorbidities, improved retention in care was observed with increasing MH service utilization. In order to achieve the US-based National HIV/AIDS Strategy goal of 90% retention in care for PLWH, MH service utilization should be considered along with other evidence-based interventions to improve retention for PLWH newly engaged in care.

1 September 2014 in Infectious Disease Clinics of North America
Verified
Journal Article
Closed access
EEEllen F. Eaton
Ellen F. Eaton
MSMichael S. Saag
Michael S. Saag
MMMichael Mugavero
Michael Mugavero

28 January 2018 in AIDS
Verified
Journal Article
Closed access
EEEllen F. Eaton
Ellen F. Eaton
ATAshutosh Tamhane
Ashutosh Tamhane
TDThibaut Davy-Mendez
Thibaut Davy-Mendez
WMWilliam C. Mathews
William C. Mathews
RMRichard D. Moore
Richard D. Moore
MMMichael J. Mugavero
Michael J. Mugavero
Objective: To evaluate the real world durability of contemporary ART for treatment-naïve people living with HIV (PLWH). Design: A retrospective follow-up study in a multisite cohort. Methods: This study of the CNICS (CFAR Network of Integrated Clinical Systems) cohort integrates data from eight Center for AIDS Research (CFARs). PLWH initiating ART between 2007 and 2014 were included. Durability was defined as time from the initiation until discontinuation/modification using Kaplan–Meier survival curves. Cox Proportional Hazards measured associations with various sociodemographic and clinical characteristics. Results: Among 5373 PLWH, the initial regimen was modified in 2285 (43%) patients. Efavirenz/emtricitabine/tenofovir (n = 2173, 40%) was the most commonly prescribed initial ART regimen; elvitegravir/cobicistat/emtricitabine/tenofovir became more common after 2012. Median durability for all regimens was 48.6 months. There were statistically significant differences in median durability for NNRTI, InSTI, and protease inhibitor-based regimens, which lasted 61, 44, and 32 months, respectively. Female sex (aHR = 1.4; 95% CI 1.2–1.6), intravenous drug use (aHR = 1.6; 95% CI 1.3–1.9), and CD4+ cell count less than 200 cells/μl (aHR = 1.2; 95% CI 1.1–1.3) were significantly associated with regimen modification. Compared with InSTI, those receiving an InSTI/protease inhibitor (aHR = 2.7; 95% CI 2.0–3.7) or protease inhibitor-based ART (aHR = 1.9; 95% CI 1.6–2.2) were significantly more likely to be modified; but those receiving NNRTI (aHR = 1.1; 95% CI 0.9–1.3) were not. Conclusion: In treatment-naive PLWH, NNRTI and InSTI-based ART were most durable, relative to protease inhibitor and InSTI/protease inhibitor-based ART, and were least likely to be modified/discontinued. A greater understanding of reasons for regimen modification/discontinuation is needed to analyze contemporary regimen durability.

15 July 2022 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
EEEllen F. Eaton
Ellen F. Eaton
KBKaylee Burgan
Kaylee Burgan
GMGreer McCollum
Greer McCollum
SLSera Levy
Sera Levy
JWJames Willig
James Willig
KCKaren Cropsey
Karen Cropsey
Background: Alabama is one of seven priority states for the National Ending the HIV Epidemic Initiative due to a large rural burden of disease. Mental health (MH) and substance use disorders (SUD) represent obstacles to HIV care in rural areas lacking Medicaid expansion and infrastructure. Evidence-informed technologies, such as telehealth, may enhance SUD and MH services but remain understudied in rural regions. Methods: We conducted a readiness assessment using a mixed methods approach to explore opportunities for enhanced SUD and MH screening using electronic patient reported outcomes (ePROs) and telehealth at five Ryan White HIV/AIDS Program-funded clinics in AL. Clinic providers and staff from each site (N = 16) completed the Organizational Readiness to Implement Change (ORIC) assessment and interviews regarding existing services and readiness to change. People with HIV from each site (PLH, N = 18) completed surveys on the acceptability and accessibility of technology for healthcare. Results: Surveys and interviews revealed that all clinics screen for depression annually by use of the Patient Health Questionnaire-9 (PHQ9). SUD screening is less frequent and unstandardized. Telehealth is available at all sites, with three of the five sites beginning services due to the COVID-19 pandemic; however, telehealth for MH and SUD services is not standardized across sites. Results demonstrate an overall readiness to adopt standardized screenings and expand telehealth services beyond HIV services at clinics. There were several concerns including Wi-Fi access, staff capacity, and patients’ technological literacy. A sample of 18 people with HIV (PWH), ages 18 to 65 years, participated in surveys; all demonstrated adequate technology literacy. A majority had accessed telehealth and were not concerned about it being too complicated or limiting communication. There were some concerns around lack of in-person interaction and lack of a physical exam and high-quality care with telehealth. Conclusion: This study of PWH and the clinics that serve them reveals opportunities to expand SUD and MH services in rural regions using technology. Areas for improvement include implementing routine SUD screening, expanding telehealth while maintaining opportunities for in-person interaction, and using standardized ePROs that are completed by patients, in order to minimize stigma and bias.